These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 26844930)

  • 1. Structural Re-engineering of the α-Helix Mimetic JY-1-106 into Small Molecules: Disruption of the Mcl-1-Bak-BH3 Protein-Protein Interaction with 2,6-Di-Substituted Nicotinates.
    Drennen B; Scheenstra JA; Yap JL; Chen L; Lanning ME; Roth BM; Wilder PT; Fletcher S
    ChemMedChem; 2016 Apr; 11(8):827-33. PubMed ID: 26844930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The novel BH3 α-helix mimetic JY-1-106 induces apoptosis in a subset of cancer cells (lung cancer, colon cancer and mesothelioma) by disrupting Bcl-xL and Mcl-1 protein-protein interactions with Bak.
    Cao X; Yap JL; Newell-Rogers MK; Peddaboina C; Jiang W; Papaconstantinou HT; Jupitor D; Rai A; Jung KY; Tubin RP; Yu W; Vanommeslaeghe K; Wilder PT; MacKerell AD; Fletcher S; Smythe RW
    Mol Cancer; 2013 May; 12(1):42. PubMed ID: 23680104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear magnetic resonance study of protein-protein interactions involving apoptosis regulator Diva (Boo) and the BH3 domain of proapoptotic Bcl-2 members.
    Santiveri CM; Sborgi L; de Alba E
    J Mol Recognit; 2012 Dec; 25(12):665-73. PubMed ID: 23192964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterodimerization of BAK and MCL-1 activated by detergent micelles.
    Liu Q; Gehring K
    J Biol Chem; 2010 Dec; 285(52):41202-10. PubMed ID: 21036904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-based design of 3-carboxy-substituted 1,2,3,4-tetrahydroquinolines as inhibitors of myeloid cell leukemia-1 (Mcl-1).
    Chen L; Wilder PT; Drennen B; Tran J; Roth BM; Chesko K; Shapiro P; Fletcher S
    Org Biomol Chem; 2016 Jun; 14(24):5505-10. PubMed ID: 26751150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-based design of N-substituted 1-hydroxy-4-sulfamoyl-2-naphthoates as selective inhibitors of the Mcl-1 oncoprotein.
    Lanning ME; Yu W; Yap JL; Chauhan J; Chen L; Whiting E; Pidugu LS; Atkinson T; Bailey H; Li W; Roth BM; Hynicka L; Chesko K; Toth EA; Shapiro P; MacKerell AD; Wilder PT; Fletcher S
    Eur J Med Chem; 2016 May; 113():273-92. PubMed ID: 26985630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BH3 profiling discriminates on-target small molecule BH3 mimetics from putative mimetics.
    Villalobos-Ortiz M; Ryan J; Mashaka TN; Opferman JT; Letai A
    Cell Death Differ; 2020 Mar; 27(3):999-1007. PubMed ID: 31332296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel BH3 mimetic efficiently induces apoptosis in melanoma cells through direct binding to anti-apoptotic Bcl-2 family proteins, including phosphorylated Mcl-1.
    Liu Y; Xie M; Song T; Sheng H; Yu X; Zhang Z
    Pigment Cell Melanoma Res; 2015 Mar; 28(2):161-70. PubMed ID: 25324174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allosteric inhibition of antiapoptotic MCL-1.
    Lee S; Wales TE; Escudero S; Cohen DT; Luccarelli J; Gallagher CG; Cohen NA; Huhn AJ; Bird GH; Engen JR; Walensky LD
    Nat Struct Mol Biol; 2016 Jun; 23(6):600-7. PubMed ID: 27159560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interdiction at a protein-protein interface: MCL-1 inhibitors for oncology.
    Li K
    Bioorg Med Chem Lett; 2021 Jan; 32():127717. PubMed ID: 33253879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pan-BH3 mimetic S1 exhibits broad-spectrum antitumour effects by cooperation between Bax and Bak.
    Song T; Xue Z; Zhang Z; Shen X; Li X
    Basic Clin Pharmacol Toxicol; 2013 Sep; 113(3):145-51. PubMed ID: 23557083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pro-apoptotic meiogynin A derivatives that target Bcl-xL and Mcl-1.
    Desrat S; Pujals A; Colas C; Dardenne J; Gény C; Favre L; Dumontet V; Iorga BI; Litaudon M; Raphaël M; Wiels J; Roussi F
    Bioorg Med Chem Lett; 2014 Nov; 24(21):5086-8. PubMed ID: 25266781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of an efficient route toward meiogynin A-inspired dual inhibitors of Bcl-xL and Mcl-1 anti-apoptotic proteins.
    Desrat S; Remeur C; Roussi F
    Org Biomol Chem; 2015 May; 13(19):5520-31. PubMed ID: 25877523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flexibility enables to discriminate between ligands: Lessons from structural ensembles of Bcl-xl and Mcl-1.
    Maity A; Majumdar S; Ghosh Dastidar S
    Comput Biol Chem; 2018 Dec; 77():17-27. PubMed ID: 30195235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based virtual screening, biological evaluation and biophysical study of novel Mcl-1 inhibitors.
    Du J; Liu L; Liu B; Yang J; Hou X; Yu J; Fang H
    Future Med Chem; 2020 Jul; 12(14):1293-1304. PubMed ID: 32397829
    [No Abstract]   [Full Text] [Related]  

  • 16. Structure and function of benzoylurea-derived alpha-helix mimetics targeting the Bcl-x(L)/Bak binding interface.
    Rodriguez JM; Ross NT; Katt WP; Dhar D; Lee GI; Hamilton AD
    ChemMedChem; 2009 Apr; 4(4):649-56. PubMed ID: 19330783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A competitive stapled peptide screen identifies a selective small molecule that overcomes MCL-1-dependent leukemia cell survival.
    Cohen NA; Stewart ML; Gavathiotis E; Tepper JL; Bruekner SR; Koss B; Opferman JT; Walensky LD
    Chem Biol; 2012 Sep; 19(9):1175-86. PubMed ID: 22999885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Small-Molecule Inhibitors of the Antiapoptotic Protein Myeloid Cell Leukaemia-1 (Mcl-1).
    Beekman AM; O'Connell MA; Howell LA
    ChemMedChem; 2016 Apr; 11(8):840-4. PubMed ID: 26616140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. To trigger apoptosis, Bak exposes its BH3 domain and homodimerizes via BH3:groove interactions.
    Dewson G; Kratina T; Sim HW; Puthalakath H; Adams JM; Colman PM; Kluck RM
    Mol Cell; 2008 May; 30(3):369-80. PubMed ID: 18471982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of Mcl-1 inhibitors from integrated high throughput and virtual screening.
    Mady ASA; Liao C; Bajwa N; Kump KJ; Abulwerdi FA; Lev KL; Miao L; Grigsby SM; Perdih A; Stuckey JA; Du Y; Fu H; Nikolovska-Coleska Z
    Sci Rep; 2018 Jul; 8(1):10210. PubMed ID: 29976942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.